SCHEMBL30229243

SCHEMBL30229243

CN1CCN(C(=O)c2cc3n(n2)CCNC3=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.46
HPGD P15428 4/20 0.45
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 1/20 0.45
MGLL Q99685 1/20 0.45
PARP1 P09874 3/20 0.44
CFTR P13569 1/20 0.43
PIM1 P11309 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HRH4 Q9H3N8 5/20 0.39
LMNA P02545 2/20 0.39
HRH3 Q9Y5N1 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3134476 0.81 PIM1 (0.43) CDC7HPGDKDM4EALDH1A1PARP1
SCHEMBL12092839 0.80 CDC7 (0.52) CDC7ALDH1A1PARP1PIM1SMN1; SMN2
SCHEMBL15009288 0.79 CDC7 (0.54) CDC7KDM4EALDH1A1PIM1SMN1; SMN2
SCHEMBL4192947 0.77 CDC7 (0.52) CDC7ALDH1A1PIM1
SCHEMBL22716058 0.77 CDC7 (0.49) CDC7HPGDKDM4EALDH1A1PARP1
SCHEMBL2572340 0.75 CDC7 (0.50) CDC7ALDH1A1PIM1
SCHEMBL2520510 0.74 CDC7 (0.46) CDC7ALDH1A1PIM1SMN1; SMN2LMNA
SCHEMBL30229287 0.72 CDC7 (0.47) CDC7KDM4EALDH1A1PARP1PIM1
SCHEMBL19902330 0.72 CDC7 (0.44) CDC7ALDH1A1MGLLPIM1SMN1; SMN2
SCHEMBL14864849 0.70 CDC7 (0.58) CDC7ALDH1A1PARP1PIM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3749669-B3 AHR MODULATORS IDEAYA BIOSCIENCES INC (US) 2024-09-04 EP claimed
EP-3749669-B1 AHR MODULATORS IDEAYA BIOSCIENCES INC (US) 2023-03-08 EP claimed